Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-12-10FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) submitted by NorthStar Rx LLC. This action represents an a…
-
FDA approval · 2010-12-08FDA Approved: PHENELZINE SULFATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals’ phenelzine sulfate as an original-application generic for the treatment of major depressive disorder. Th…
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Expanding Rural Access: Distance Delivery of Support Groups (Main Study) [Phase 3]
Update on a Phase 3 trial evaluating distance-delivery support groups to expand rural access for patients with depression and breast cancer;…
-
FDA approval · 2010-12-01FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA label_change · 2010-12-01FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., resulting in change…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks [NA]
A completed single-blind trial comparing risperidone to paroxetine for treatment of panic attacks in people with major depressive disorder w…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder [Phase 3]
Phase 3 study evaluating desvenlafaxine succinate sustained-release in outpatients with major depressive disorder completed; results posted …
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Depression and Anxiety in the Aetiology and Prognosis of Specific Cardiovascular Disease Syndromes: a CALIBER Study
This CALIBER clinical trial update examines how depression and anxiety relate to the etiology and prognosis of coronary disease and broader …
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment [Phase 4]
Phase 4 clinical trial evaluating AndroGel (testosterone gel) in men with major depressive disorder who had incomplete response to antidepre…
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression [Phase 3]
Phase 3 trial assessing quetiapine extended-release (Seroquel XR) as an adjunctive treatment for cognition, mood, and anxiety in SSRI-resist…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) [Phase 3]
A Phase 3 double-blind, placebo-controlled trial evaluated a controlled-release formulation of paroxetine in major depressive disorder; resu…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention [Phase 1]
Phase 1 study evaluating an internet-based intervention to improve quality of life and depressive symptoms among combat veterans. The trial …
-
CLINICAL_TRIALS research · 2010-10-28Clinical Trial Update: Mindfulness and Lifestyle Interventions for Depression and Anxiety: A Pilot Study [NA]
A pilot study investigating mindfulness and lifestyle interventions for depression and anxiety; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial of vilazodone for major depressive disorder assessed efficacy, safety, and biom…
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: Regulation of Intracerebral Pressure During Electroconvulsive Therapy
A completed clinical trial evaluating how intracerebral pressure is regulated during electroconvulsive therapy in patients with depression.
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: Effects of Emotional Stimulation on the Stress Levels of Healthy Persons [Phase 1, Phase 2]
A Phase 1/2 clinical trial update studying how emotional stimulation affects stress levels in healthy volunteers, with interest in depressio…
-
FDA approval · 2010-10-18FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (Pfizer), val…
-
FDA approval · 2010-10-15FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride (generic) from Zydus Lifesciences Limited, authorizing a generic paroxe…
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Homing in on Health: Study of a Home Delivered Chronic Disease Self Management Program [NA]
Completed clinical trial evaluating a home-delivered chronic disease self-management program. The study was sponsored by the Agency for Heal…
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: Effects of Antidepressants on Sexual Functioning [Phase 3]
A Phase 3 trial update from GlaxoSmithKline evaluated how antidepressants affect sexual functioning in adults with major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder [Phase 2]
Phase 2 clinical trial update for an 8-week study in adults with Major Depressive Disorder, sponsored by GlaxoSmithKline; the study status i…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients [Phase 4]
Phase 4 trial comparing duloxetine to placebo in elderly patients with major depressive disorder; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder [Phase 2]
Phase 2 trial of Lu AA34893 for Major Depressive Disorder has been terminated; no efficacy or safety results are provided in this update.
-
CLINICAL_TRIALS research · 2010-09-24Clinical Trial Update: Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study [NA]
A completed pilot clinical trial evaluating mindfulness-based stress reduction for post-traumatic stress disorder (PTSD), with co-occurring …
-
FDA label_change · 2010-09-20FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride by PAI Holdings to modify the product labeling.